1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Insulinoma Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Benign 1.2.3 Metastatic 1.3 Market by Application 1.3.1 Global Insulinoma Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Research and Academic Institutions 1.3.5 Biotechnology and Pharmaceutical Companies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Insulinoma Market Perspective (2017-2028) 2.2 Insulinoma Growth Trends by Region 2.2.1 Insulinoma Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Insulinoma Historic Market Size by Region (2017-2022) 2.2.3 Insulinoma Forecasted Market Size by Region (2023-2028) 2.3 Insulinoma Market Dynamics 2.3.1 Insulinoma Industry Trends 2.3.2 Insulinoma Market Drivers 2.3.3 Insulinoma Market Challenges 2.3.4 Insulinoma Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Insulinoma Players by Revenue 3.1.1 Global Top Insulinoma Players by Revenue (2017-2022) 3.1.2 Global Insulinoma Revenue Market Share by Players (2017-2022) 3.2 Global Insulinoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Insulinoma Revenue 3.4 Global Insulinoma Market Concentration Ratio 3.4.1 Global Insulinoma Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Insulinoma Revenue in 2021 3.5 Insulinoma Key Players Head office and Area Served 3.6 Key Players Insulinoma Product Solution and Service 3.7 Date of Enter into Insulinoma Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Insulinoma Breakdown Data by Type 4.1 Global Insulinoma Historic Market Size by Type (2017-2022) 4.2 Global Insulinoma Forecasted Market Size by Type (2023-2028) 5 Insulinoma Breakdown Data by Application 5.1 Global Insulinoma Historic Market Size by Application (2017-2022) 5.2 Global Insulinoma Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Insulinoma Market Size (2017-2028) 6.2 North America Insulinoma Market Size by Country (2017-2022) 6.3 North America Insulinoma Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Insulinoma Market Size (2017-2028) 7.2 Europe Insulinoma Market Size by Country (2017-2022) 7.3 Europe Insulinoma Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Insulinoma Market Size (2017-2028) 8.2 Asia-Pacific Insulinoma Market Size by Country (2017-2022) 8.3 Asia-Pacific Insulinoma Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Insulinoma Market Size (2017-2028) 9.2 Latin America Insulinoma Market Size by Country (2017-2022) 9.3 Latin America Insulinoma Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Insulinoma Market Size (2017-2028) 10.2 Middle East & Africa Insulinoma Market Size by Country (2017-2022) 10.3 Middle East & Africa Insulinoma Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Abcam 11.1.1 Abcam Company Detail 11.1.2 Abcam Business Overview 11.1.3 Abcam Insulinoma Introduction 11.1.4 Abcam Revenue in Insulinoma Business (2017-2022) 11.1.5 Abcam Recent Development 11.2 Ciron Group 11.2.1 Ciron Group Company Detail 11.2.2 Ciron Group Business Overview 11.2.3 Ciron Group Insulinoma Introduction 11.2.4 Ciron Group Revenue in Insulinoma Business (2017-2022) 11.2.5 Ciron Group Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Detail 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Insulinoma Introduction 11.3.4 Pfizer Revenue in Insulinoma Business (2017-2022) 11.3.5 Pfizer Recent Development 11.4 Entax Medical 11.4.1 Entax Medical Company Detail 11.4.2 Entax Medical Business Overview 11.4.3 Entax Medical Insulinoma Introduction 11.4.4 Entax Medical Revenue in Insulinoma Business (2017-2022) 11.4.5 Entax Medical Recent Development 11.5 Olympus 11.5.1 Olympus Company Detail 11.5.2 Olympus Business Overview 11.5.3 Olympus Insulinoma Introduction 11.5.4 Olympus Revenue in Insulinoma Business (2017-2022) 11.5.5 Olympus Recent Development 11.6 Boston Scientific Corporation 11.6.1 Boston Scientific Corporation Company Detail 11.6.2 Boston Scientific Corporation Business Overview 11.6.3 Boston Scientific Corporation Insulinoma Introduction 11.6.4 Boston Scientific Corporation Revenue in Insulinoma Business (2017-2022) 11.6.5 Boston Scientific Corporation Recent Development 11.7 Medtronic 11.7.1 Medtronic Company Detail 11.7.2 Medtronic Business Overview 11.7.3 Medtronic Insulinoma Introduction 11.7.4 Medtronic Revenue in Insulinoma Business (2017-2022) 11.7.5 Medtronic Recent Development 11.8 Cook Medical 11.8.1 Cook Medical Company Detail 11.8.2 Cook Medical Business Overview 11.8.3 Cook Medical Insulinoma Introduction 11.8.4 Cook Medical Revenue in Insulinoma Business (2017-2022) 11.8.5 Cook Medical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Insulinoma Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Benign Table 3. Key Players of Metastatic Table 4. Global Insulinoma Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Insulinoma Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Insulinoma Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Insulinoma Market Share by Region (2017-2022) Table 8. Global Insulinoma Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Insulinoma Market Share by Region (2023-2028) Table 10. Insulinoma Market Trends Table 11. Insulinoma Market Drivers Table 12. Insulinoma Market Challenges Table 13. Insulinoma Market Restraints Table 14. Global Insulinoma Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Insulinoma Market Share by Players (2017-2022) Table 16. Global Top Insulinoma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulinoma as of 2021) Table 17. Ranking of Global Top Insulinoma Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Insulinoma Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Insulinoma Product Solution and Service Table 21. Date of Enter into Insulinoma Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Insulinoma Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Insulinoma Revenue Market Share by Type (2017-2022) Table 25. Global Insulinoma Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Insulinoma Revenue Market Share by Type (2023-2028) Table 27. Global Insulinoma Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Insulinoma Revenue Market Share by Application (2017-2022) Table 29. Global Insulinoma Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Insulinoma Revenue Market Share by Application (2023-2028) Table 31. North America Insulinoma Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Insulinoma Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Insulinoma Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Insulinoma Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Insulinoma Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Insulinoma Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Insulinoma Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Insulinoma Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Insulinoma Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Insulinoma Market Size by Country (2023-2028) & (US$ Million) Table 41. Abcam Company Detail Table 42. Abcam Business Overview Table 43. Abcam Insulinoma Product Table 44. Abcam Revenue in Insulinoma Business (2017-2022) & (US$ Million) Table 45. Abcam Recent Development Table 46. Ciron Group Company Detail Table 47. Ciron Group Business Overview Table 48. Ciron Group Insulinoma Product Table 49. Ciron Group Revenue in Insulinoma Business (2017-2022) & (US$ Million) Table 50. Ciron Group Recent Development Table 51. Pfizer Company Detail Table 52. Pfizer Business Overview Table 53. Pfizer Insulinoma Product Table 54. Pfizer Revenue in Insulinoma Business (2017-2022) & (US$ Million) Table 55. Pfizer Recent Development Table 56. Entax Medical Company Detail Table 57. Entax Medical Business Overview Table 58. Entax Medical Insulinoma Product Table 59. Entax Medical Revenue in Insulinoma Business (2017-2022) & (US$ Million) Table 60. Entax Medical Recent Development Table 61. Olympus Company Detail Table 62. Olympus Business Overview Table 63. Olympus Insulinoma Product Table 64. Olympus Revenue in Insulinoma Business (2017-2022) & (US$ Million) Table 65. Olympus Recent Development Table 66. Boston Scientific Corporation Company Detail Table 67. Boston Scientific Corporation Business Overview Table 68. Boston Scientific Corporation Insulinoma Product Table 69. Boston Scientific Corporation Revenue in Insulinoma Business (2017-2022) & (US$ Million) Table 70. Boston Scientific Corporation Recent Development Table 71. Medtronic Company Detail Table 72. Medtronic Business Overview Table 73. Medtronic Insulinoma Product Table 74. Medtronic Revenue in Insulinoma Business (2017-2022) & (US$ Million) Table 75. Medtronic Recent Development Table 76. Cook Medical Company Detail Table 77. Cook Medical Business Overview Table 78. Cook Medical Insulinoma Product Table 79. Cook Medical Revenue in Insulinoma Business (2017-2022) & (US$ Million) Table 80. Cook Medical Recent Development Table 81. Research Programs/Design for This Report Table 82. Key Data Information from Secondary Sources Table 83. Key Data Information from Primary Sources List of Figures Figure 1. Global Insulinoma Market Share by Type: 2021 VS 2028 Figure 2. Benign Features Figure 3. Metastatic Features Figure 4. Global Insulinoma Market Share by Application in 2021 & 2028 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Research and Academic Institutions Case Studies Figure 8. Biotechnology and Pharmaceutical Companies Case Studies Figure 9. Insulinoma Report Years Considered Figure 10. Global Insulinoma Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Insulinoma Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Insulinoma Market Share by Region: 2021 VS 2028 Figure 13. Global Insulinoma Market Share by Players in 2021 Figure 14. Global Top Insulinoma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulinoma as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Insulinoma Revenue in 2021 Figure 16. North America Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Insulinoma Market Share by Country (2017-2028) Figure 18. United States Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Insulinoma Market Share by Country (2017-2028) Figure 22. Germany Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Insulinoma Market Share by Region (2017-2028) Figure 30. China Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Insulinoma Market Share by Country (2017-2028) Figure 38. Mexico Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Insulinoma Market Share by Country (2017-2028) Figure 42. Turkey Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Insulinoma Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Abcam Revenue Growth Rate in Insulinoma Business (2017-2022) Figure 45. Ciron Group Revenue Growth Rate in Insulinoma Business (2017-2022) Figure 46. Pfizer Revenue Growth Rate in Insulinoma Business (2017-2022) Figure 47. Entax Medical Revenue Growth Rate in Insulinoma Business (2017-2022) Figure 48. Olympus Revenue Growth Rate in Insulinoma Business (2017-2022) Figure 49. Boston Scientific Corporation Revenue Growth Rate in Insulinoma Business (2017-2022) Figure 50. Medtronic Revenue Growth Rate in Insulinoma Business (2017-2022) Figure 51. Cook Medical Revenue Growth Rate in Insulinoma Business (2017-2022) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Abcam Ciron Group Pfizer Entax Medical Olympus Boston Scientific Corporation Medtronic Cook Medical